Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas

by Pawel Sadlecki, Dariusz Grzanka, Marek Grabiec
Published 2018-01-01

Ocena stężeń naskórkowego czynnika wzrostu w surowicy kobiet leczonych z powodu nabłonkowych guzów jajnika

by Marek Grabiec, Małgorzata Walentowicz-Sadłecka, Paweł Sadłecki
Published 2011-06-01

Rola angiogenezy w rozwoju nowotworów

by Paweł Sadłecki, Małgorzata Walentowicz-Sadłecka, Marek Grabiec
Published 2010-02-01

Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus.

by Pawel Sadlecki, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Published 2016-01-01

Broad ligament pregnancy – A rare and challenging diagnosis

by Paweł Sadłecki, Marek Grabiec, Małgorzata Walentowicz‐Sadłecka
Published 2021-09-01

Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers

by Pawel Sadlecki, Jakub Jóźwicki, Paulina Antosik, Marek Grabiec
Published 2018-06-01

Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer

by Paweł Sadłecki, Jakub Jóźwicki, Paulina Antosik, Małgorzata Walentowicz-Sadłecka
Published 2020-01-01

Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testing

by Pawel Sadlecki, Marek Grabiec, Pawel Walentowicz, Malgorzata Walentowicz-Sadlecka
Published 2018-05-01

KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system

by Pawel Sadlecki, Paulina Antosik, Dariusz Grzanka, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Published 2017-10-01

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers

by Paweł Sadłecki, Marek Grabiec, Dariusz Grzanka, Jakub Jóźwicki, Paulina Antosik, Małgorzata Walentowicz-Sadłecka
Published 2019-03-01

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers

by Pawel Sadlecki, Pawel Walentowicz, Magdalena Bodnar, Andrzej Marszalek, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Published 2017-05-01

The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients

by Malgorzata Walentowicz-Sadlecka, Bogdan Malkowski, Pawel Walentowicz, Pawel Sadlecki, Andrzej Marszalek, Tomasz Pietrzak, Marek Grabiec
Published 2014-01-01

Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.

by Pawel Walentowicz, Magdalena Krintus, Pawel Sadlecki, Marek Grabiec, Aneta Mankowska-Cyl, Alina Sokup, Malgorzata Walentowicz-Sadlecka
Published 2014-01-01

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer

by Pawel Walentowicz, Pawel Sadlecki, Magdalena Krintus, Grazyna Sypniewska, Aneta Mankowska-Cyl, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Published 2013-01-01

The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

by Pawel Sadlecki, Magdalena Bodnar, Marek Grabiec, Andrzej Marszalek, Pawel Walentowicz, Alina Sokup, Jolanta Zegarska, Małgorzata Walentowicz-Sadlecka
Published 2014-01-01

Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients.

by Malgorzata Walentowicz-Sadlecka, Pawel Sadlecki, Magdalena Bodnar, Andrzej Marszalek, Pawel Walentowicz, Alina Sokup, Arnika Wilińska-Jankowska, Marek Grabiec
Published 2014-01-01

Serum 25(OH) Vitamin D Levels in Polish Women during Pregnancies Complicated by Hypertensive Disorders and Gestational Diabetes

by Piotr Domaracki, Pawel Sadlecki, Grazyna Odrowaz-Sypniewska, Ewa Dzikowska, Pawel Walentowicz, Joanna Siodmiak, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Published 2016-09-01

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)

by Malgorzata Walentowicz-Sadlecka, Piotr Domaracki, Pawel Sadlecki, Joanna Siodmiak, Marek Grabiec, Pawel Walentowicz, Maria Teresa Arias Moliz, Grazyna Odrowaz-Sypniewska
Published 2019-01-01